Clinical Significance of NKD Inhibitor of WNT Signaling Pathway 1 (NKD1) in Glioblastoma
Introduction. As the most malignant type of gliomas, glioblastoma is characterized with disappointing prognosis. Here, we aimed to investigate expression and function of NKD inhibitor of Wnt signaling pathway 1 (NKD1), an antagonist of Wnt-beta-catenin signaling pathways, in glioblastoma. Methods. T...
Saved in:
Main Authors: | Lijun Li, Ruiying Gao, Weizhong Huangfu, Fang Zhang, Ruixia Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-01-01
|
Series: | Genetics Research |
Online Access: | http://dx.doi.org/10.1155/2023/1184101 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Kindlin-1 promotes gastric cancer cell motility through the Wnt/β-catenin signaling pathway
by: Jun-Ho Jang, et al.
Published: (2025-01-01) -
The Role of C1-Esterase Inhibitors in the Management of Vasogenic Edema in Glioblastoma
by: Gillian R. Naro, et al.
Published: (2020-01-01) -
Revisiting ABC Transporters and Their Clinical Significance in Glioblastoma
by: Brandon Wee Siang Phon, et al.
Published: (2025-01-01) -
Prednisone inhibits osteosarcoma cell by regulating the Wnt/β-catenin signaling pathway
by: Yo Zhang, et al.
Published: (2024-12-01) -
WNT3A promotes the cementogenic differentiation of dental pulp stem cells through the FOXO1 signaling pathway
by: Dongmei Cheng, et al.
Published: (2025-02-01)